Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment

BACKGROUND: Ticagrelor is a first-line drug for the treatment of acute ST elevation myocardial infarction (STEMI). However, approximately 20% STEMI patients taking ticagrelor exhibited a delayed response and the mechanism was still unclear. METHODS: To explore the mechanism of the poor response of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Zhang, Xiaolin, Tong, Fangnian, Cai, Yi, Zhang, Yujie, Song, Haixu, Tian, Xiaoxiang, Yan, Chenghui, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903831/
https://www.ncbi.nlm.nih.gov/pubmed/35258452
http://dx.doi.org/10.7554/eLife.70240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903831/
https://www.ncbi.nlm.nih.gov/pubmed/35258452
http://dx.doi.org/10.7554/eLife.70240

Ejemplares similares